FDBusiness.com

Lipogen Gains US Patent for PMS/PMDD Relief

 Breaking News
  • Glanbia’s Strategic Evolution Continues Glanbia, the global nutrition group, has reported a 7% rise in wholly owned revenue from continuing operations to €2.387 billion (up 9.2% constant currency) for the financial year ended 30 December 2017. The drivers of this revenue growth were a 5.3% improvement in volume, a 0.2% increase in price and a 3.7% contribution from acquisitions. [...]...
  • Green Light For Acquisition of Bake & Co by Dr Oetker The European Commission has approved, under the EU Merger Regulation, the acquisition of Bake & Co of Belgium by Dr Oetker of Germany. Bake & Co supplies frozen bakery products sold as ‘bake-off’ to retail and food service customers. Dr Oetker is active in the supply of food products, alcoholic and non-alcoholic beverages, specialty phosphates, [...]...
  • Harrogate Water Announces Move to Recycled PET Plastic In a landmark move towards achieving a circular economy, Harrogate Water, Britain’s oldest bottled water brand, has announced it has successfully secured sufficient availability of recycled PET (rPET), to ensure all product shall contain 50 per cent recycled content from April 2018. The amount of recycled PET content, all guaranteed UK post-consumer supply, will match that [...]...
  • Meyn Introduces New Meyn Vent Cutter 240 For Vent Drilling at High Speeds The new Vent cutter 240 has been designed to operate at high speeds, up to 13,500 bph without sacrificing accuracy or adding yield loss. Optimal positioning of the bird relative to the vent knife before and during drilling ensures the most optimal cut independent of the weight ranges that are processed. The machine ensures consistently low [...]...
  • Arla Foods Achieves Record Organic Revenue Growth in 2017 Strong performances by Arla Foods’ global brands, its international markets, and the ingredients business ensured a year of high growth for international dairy co-operative Arla Foods in 2017, as it delivered a 27.4% increase in pre-paid milk price to its farmer owners, and a net profit of 2.8% of revenue within its target range. This was [...]...

Lipogen Gains US Patent for PMS/PMDD Relief

February 22
15:03 2016

Lipogen Targets PMS Relief, NaturallyLipogen Ltd.  attained a US patent for its proprietary phospholipid formulation designed to tackle Premenstrual Syndrome (PMS) and premenstrual dysphoric disorder (PMDD). These sometimes debilitating conditions occur in some 15% of pre-menopausal women aged 25-44. The patent was approved for “compositions and methods for alleviating symptoms associated with premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD).”

PMS is a combination of physical and emotional symptoms linked to the menstrual cycle. PMS symptoms occur 1 to 2 weeks before a woman’s period. Up to 80% women report having some symptoms prior to menstruation. These symptoms qualify as PMS in 20% to 30% of pre-menopausal women. According to the Medical University of South Carolina, current available treatments include SSRIs and other drug treatments that treat side effects and can cost from US$60.00 – US$535.00 per month.

More than 200 different symptoms have been associated with PMS, including emotional symptoms such as: stress, anxiety, insomnia, fatigue, mood swings, emotional sensitivity and/or changes in libido. Physical symptoms can include bloating, abdominal cramps, constipation, lower back pain, acne, breast swelling, muscle pain and others.

“When the benefits of phospholipids on PMS and PMDD came to light through Lipogen’s research, we immediately explored its potential,” says David Rutenberg, CEO for Lipogen. “Realizing the significance of this discovery, it encouraged us to further explore a product line for women’s health utilizing Lipogen’s proprietary phospholipid ingredients.”

The previously unrecognized PMS/PMDD benefit of PS Plus came about when 2,000 volunteers received and consumed Lipogen’s PS Plus for brain health and stress management. At the end of the 2-month study, out of 220 women under the age of 40 who consumed the product regularly, 23 women (10.45%) reported that they noticed relief of premenstrual syndromes. They also reported that it helped them sleep better, experience fewer mood swings, fewer hot flashes and reduced stress.

“Based on these strong results, we improved the formulation and applied for a patent in the US market,” explains Rutenberg. “We also have begun an ongoing, double-blind, randomized, placebo-controlled clinical trial with daacro GmbH, Trier, Germany, to learn more how Lipogen’s formulation can help alleviate PMS and PMDD symptoms. Our patented solution is made of natural ingredients, is GMO-free, and can save significant health costs over medication alternatives, all with no reported side-effects.”

With 25 years of specializing in natural phospholipid research, development and production, Lipogen guarantees its customers ingredient systems that are supported by the highest level of scientific data, technical quality and safety to meet the growing demand for natural cognitive health solutions.

About Author

admin

admin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • February 25, 2018fish international
  • February 27, 2018Warsaw Gastro Show
  • February 27, 2018Int'l Food Fair
  • February 28, 2018GAST
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements